Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Corsello

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|January 28, 2025
Development of Potent and Selective CK1α Molecular Glue DegradersQixiang Geng, Zixuan Jiang, Woong Sub Byun, et al.
Science (New York, N.Y.)|March 17, 2022
Copper induces cell death by targeting lipoylated TCA cycle proteinsPeter Tsvetkov, Shannon Coy, Boryana Petrova, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Ratiometric transcriptional activation by protein degradationMelissa A Gray, Katelyn L Randal, Jennifer A Co, et al.
Cell Chemical Biology|May 27, 2026
The molecular basis for nuclear pore destruction by a proximity-inducing molecular glueStephen M Hinshaw, Linjie Yuan, Md Abdullah Al Noman, et al.
Cancer Immunology Research|June 21, 2019
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal CancerCarino Gurjao, David Liu, Matan Hofree, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Journal of Medicinal Chemistry|March 22, 2023
Structure-Based Design of Y-Shaped Covalent TEAD InhibitorsWenchao Lu, Mengyang Fan, Wenzhi Ji, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Cancer Discovery|May 6, 2016
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic AllelesEejung Kim, Nina Ilic, Yashaswi Shrestha, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|January 28, 2025
Development of Potent and Selective CK1α Molecular Glue DegradersQixiang Geng, Zixuan Jiang, Woong Sub Byun, et al.
Science (New York, N.Y.)|March 17, 2022
Copper induces cell death by targeting lipoylated TCA cycle proteinsPeter Tsvetkov, Shannon Coy, Boryana Petrova, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Ratiometric transcriptional activation by protein degradationMelissa A Gray, Katelyn L Randal, Jennifer A Co, et al.
Cell Chemical Biology|May 27, 2026
The molecular basis for nuclear pore destruction by a proximity-inducing molecular glueStephen M Hinshaw, Linjie Yuan, Md Abdullah Al Noman, et al.
Cancer Immunology Research|June 21, 2019
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal CancerCarino Gurjao, David Liu, Matan Hofree, et al.
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Journal of Medicinal Chemistry|March 22, 2023
Structure-Based Design of Y-Shaped Covalent TEAD InhibitorsWenchao Lu, Mengyang Fan, Wenzhi Ji, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Nature|June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin KMikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Cancer Discovery|May 6, 2016
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic AllelesEejung Kim, Nina Ilic, Yashaswi Shrestha, et al.
Pageof 3